Effect Of Certolizumab Pegol On The Multiple Facets Of Psoriatic Arthritis As Reported By Patients- 24-Week Patient Reported Outcome Results Of A Phase 3 Double Blind Randomized Placebo-Controlled Study
Abstract
Authors
D. Gladman R. Fleischmann G. Coteur F. Woltering P. Mease